Ivermectin shows 'antiviral effect' against Covid-19, Japanese company says

📆 01/02/2022 09:21:00
📰 asiaonecom

⏱ Reading Time:
19 sec. here
2 min. at publisher
📊 Quality Score:
News: 11%
Publisher: 59%

Portugal Notícia Notícia

Portugal Últimas Notícias,Portugal Manchetes

TOKYO - Japanese trading and pharmaceuticals company Kowa Co Ltd on Monday (Jan 31) said that anti-parasite drug ivermectin showed an 'antiviral effect' against Omicron and other coronavirus variants in joint non-clinical research. The company, which has been working with Tokyo's Kitasato University on testing the drug as a potential treatment for Covid-19, did not provide further details. Clinical trials...

TOKYO - Japanese trading and pharmaceuticals company Kowa Co Ltd on Monday said that anti-parasite drug ivermectin showed an "antiviral effect" against Omicron and other coronavirus variants in joint non-clinical research.

Clinical trials are ongoing, but promotion of ivermectin as a Covid-19 treatment has generated controversy. The use of ivermectin to treat Covid-19 is currently being investigated in a UK trial run by the University of Oxford. The researchers said on Monday that it was still under way and they did not want to comment further until they have results to report.

Resumimos esta notícia para que você possa lê-la rapidamente. Se você se interessou pela notícia, pode ler o texto completo aqui. Consulte Mais informação:

Escrever Comentário

Portugal Últimas Notícias, Portugal Manchetes

Similar News:Você também pode ler notícias semelhantes a esta que coletamos de outras fontes de notícias.

Ivermectin shows 'antiviral effect' against Covid-19, Japanese company saysstraits_times IVERMECTIN - Anti-Viral, Anti-Cancer, etc. So many Benefits. Yet we are being denied the chance. Is it Fair? And its Very affordable. No wonder Big Companies hate it and say many bad things. What a world.
Fonte: STForeignDesk - 🏆 4. / 71 Consulte Mais informação »